Global Direct-To-Consumer Genetic Testing Market Revenue Is Nearly 640 Million USD In 2017
Friday, 15 Nov, 2019
Most of the time, genetic testing is done through healthcare providers such as physicians, nurse practitioners, and genetic counselors. Healthcare providers determine which test is needed, order the test from a laboratory, collect and send the DNA sample, interpret the test results, and share the results with the patient. Often, a health insurance company covers part or all of the cost of testing.

In the last several years, global market of Direct-to-consumer Genetic Testing developed rapidly, with an average growth rate of 21.1% during 2013 to 2018. In 2017, global revenue of Direct-to-consumer Genetic Testing is nearly 640 Million USD. Due to increasing awareness about whole genomic analysis for the early detection of diseases drive the global market growth. The growing incidence of chronic diseases such as breast and colorectal cancer, neurological disorders such as Parkinson’s disease, and other diseases such as sickle cell anemia (SCA) is also driving the growth of the market. growth of the direct-to-consumer genetic testing market is born out of a paradigm shift among consumers who are seeking greater control over their own healthcare.

The classification of Direct-to-consumer Genetic Testing includes Diagnostic?Screening, PGD and Relationship?Testing, and the proportion of Relationship?Testing in 2017 is about 56.4%, and the proportion is in increasing trend from 2013 to 2018. Relationship testing, also known as family deoxyribonucleic acid (DNA) testing, helps determine the relationship between grandparents, mother, father, and siblings. Diagnostic screening is mostly conducted to evaluate major treatment decisions. Diagnostic testing helps identify genes that are responsible for chronic diseases such as cancer. Diagnostic testing includes hereditary testing and carrier screening, which is usually conducted for DTC genetic testing and the market share in 2017 is about 29.3%

Direct-to-consumer Genetic Testing is widely sales through Online, Offline. The most proportion of Direct-to-consumer Genetic Testing is sales through Online, and the proportion in 2017 is 64.9%. 

North America is the largest consumption place, with a consumption market share nearly 64.8% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 19.6%.